Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the thr
ee month period ended June 30, 2014.
Quarter ended June 30, 2014 Highlights - compared to June 30, 2013
•Net sales of $130 million, decreased $23 million, on a slight increase in volumes. Help employers find you! Check out all the jobs and post your resume.
